Despite the backdrop of rapid growth, medical innovation, increasing legalization efforts, and tremendous consumer demand, many large companies including financial institutions, publicly listed firms, and institutional investors (pension funds/endowments) are unable, due to Federal illegality, to participate in the cannabis industry. Further, the legal complexity and associated barriers-to-entry have substantially constrained the supply of capital to the space thereby limiting the ability for cannabis businesses to expand outside of the primary state in which they operate. Further, due to the infancy of the market and its history as an illicit, “black market” business, many of the existing management teams lack the sophistication and skills necessary to compete as the market expands, and inevitably, becomes fully legitimized.